期刊文献+

大肠癌患者血浆D二聚体和纤维蛋白原浓度变化及临床意义 被引量:13

The research on the changes of the D-dimer and fibrinogen concentrations in the patients with colorectal carcinoma
暂未订购
导出
摘要 目的:研究大肠癌患者血浆D二聚体和纤维蛋白原浓度的变化及意义。方法:选择大肠癌患者34例及良性病患者31例,于术前采血并检测血浆D二聚体和纤维蛋白原浓度,然后进行统计分析。同时,大肠癌患者组内按照Dukes分期标准分为4组,并对组间D二聚体水平进行比较。结果:大肠癌患者的D二聚体水平显著高于对照组(P<0.05)。同样,两组之间的纤维蛋白原水平亦有显著差别,大肠癌患者组显著高于对照组(P<0.05)。在大肠癌患者的各亚组中,Dukes D期患者的D二聚体水平明显高于其他各期(P<0.05)。结论:大肠癌患者血液处于高凝状态,并且D二聚体对大肠癌的分期及预后可能有一定的指导意义。 Objective: To study the changes of the plasma concentrations of the D-dimer and fibrinogen in the patients with colorectal carcinoma. Methods: Preoperative plasma D-dimer and fibrinogen levels were measured in 34 patients with colorectal carcinoma and 31 patients with benign disease. At the same time , the patients with colorectal carcinoma were divided into 4 groups according to the Dukes, classification and the D-dimer levels measured. Results: Preoperative plasma D-dimer and fibrinogen levels were significantly higher in patients with colorectal carcinoma than those with benign diseases (P〈0.05). Among the subgroups of the patients with colorectal carcinoma, the D-dimer level of the Dukes D group was the highest (P〈0.05). Conclusion: The blood of the patients with colorectal carcinoma is in a hypercoagulability condition. The D-dimer plasma level maybe useful for the staging and prognosis of the patients with colorectal carcinoma.
作者 靳小石
出处 《天津医科大学学报》 2006年第3期404-405,408,共3页 Journal of Tianjin Medical University
关键词 大肠癌 D二聚体 纤维蛋白原 Colorectal carcinoma D-dimer Fibrinogen
  • 相关文献

参考文献10

  • 1Blackwell K,Hurwitz H,Lieberman G,et al.Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma[J].Cancer,2004,101(1):77
  • 2Masatoshi O,Yoshitake A,Takashi O,et al.High preoperative plasma D-dimer level is associtated with advanced tumor and short survival after curative resection in patients with colorectal cancer[J].Jpn J Clin Oncol,2001,31(8):388
  • 3Aliustaoglu M,Yumuk PF,Gurrms M,et al.D-dimer can it be a marker for malignant gastric lesions[J].Acta Oncol,2004,43(8):770
  • 4Sallah S,Husain A,Sigounas V,et al.Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease re ceivingoralanticoagulationtherapy[J].Clin Cancer Res,2004,10(21):7 238
  • 5黄尉国,王鸿利,张颖琪,朱立红,李耀辉,王学锋,程寅琳,邵慧珍,张鲁,葛维成.血浆D-二聚体检测及其临床应用[J].中华医学检验杂志,1995,18(2):71-74. 被引量:318
  • 6Tseng CS,Lo HW,Chen PH,et al.Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma[J].Hepatogastroenterology,2004,51(59):1 454
  • 7Kakkar AK,DeRuvo N,Chinswangwatanakul V,et al.Extrinsicpathway activation in cancer with high factor Ⅶ a and tissue factor[J].Lancet,1995,346(8 981):1 004
  • 8Gordon SG,Chelladurai M.Non-tissue factor procoagulants in cancer cell[J].Cancer Metastasis Rev,1992,11(3/4):267
  • 9Dupuy E,Habib A,Lebret M,et al.Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells:possible relevance to HIF-1α[J].J Thromb Haemost,2003,1(5):1 096
  • 10Beer JH,Haeberli A,Vogt A,et al.Coagulation markers predict survival in cancer patients[J].Thromb Haemost,2002,88(5):745

共引文献317

同被引文献119

引证文献13

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部